Literature DB >> 24941709

Pathophysiology and management of post resection liver failure.

I Colle, X Verhelst, A Vanlander, A Geerts, H Van Vlierberghe, F Berrevoet, X Rogiers, R I Troisi.   

Abstract

Post resection liver failure (PRLF) is defined by the occurrence of jaundice, coagulopathy and encephalopathy after liver resection. When PRLF is present, it has a high morbidity and mortality. The incidence of PRLF ranges between 0-30%. For having a healthy regeneration of the liver remnant an adequate number of hepatocytes and nonparenchymal cells, a normal functional and regenerative capacity and also a good accommodation of haemodynamic changes without congestion are needed. To avoid the presence of PRLF ongoing parenchymal damage after the liver resection should be avoided. So, ischemia reperfusion injury should be minimalized, infection and sepsis should be treated immediately and small for size syndrome should be avoided.

Entities:  

Mesh:

Year:  2013        PMID: 24941709     DOI: 10.1080/00015458.2013.11680904

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  3 in total

1.  Resina Draconis Reduces Acute Liver Injury and Promotes Liver Regeneration after 2/3 Partial Hepatectomy in Mice.

Authors:  Zhi-Yong He; Kai-Han Lou; Jia-Hui Zhao; Ming Zhang; Lan-Chun Zhang; Ju Li; Hao-Fei Yu; Rong-Ping Zhang; Hu Wei-Yan
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-07       Impact factor: 2.629

2.  Differential Effects of Three Techniques for Hepatic Vascular Exclusion during Resection for Liver Cirrhosis on Hepatic Ischemia-Reperfusion Injury in Rats.

Authors:  Changjun Jia; Chaoliu Dai; Hailiang Wang; Yi Wan; Yunyu Qiao; Feng Xu; Songlin Peng; Yang Zhao; Chuang Zhao; Liang Zhao
Journal:  Gastroenterol Res Pract       Date:  2018-01-08       Impact factor: 2.260

3.  Assessment of remnant liver function and volume after selective ligation of portal vein and hepatic artery in a rat model.

Authors:  Thiago Boechat de Abreu; Alexandre de Abreu Ribeiro; Lívia Paola Colchete Provenzano; Joaquim Ribeiro Filho; Alberto Schanaider
Journal:  Acta Cir Bras       Date:  2020-01-10       Impact factor: 1.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.